Ebony Hargrove-Wiley

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Replacement Therapy

Breast Cancer Cells

Dna Methylation

Histone Deacetylase

Top Venues

International journal of molecular sciences

Research square

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Demond Williams, Ebony Hargrove-Wiley, Wendy Bindeman, Daniel Valent, Adam X Miranda, Jacob Beckstead, Barbara Fingleton
Type II Interleukin-4 Receptor Activation in Basal Breast Cancer Cells Promotes Tumor Progression via Metabolic and Epigenetic Modulation. International journal of molecular sciences 25 (9) (2024)
Demond Williams, Ebony Hargrove-Wiley, Wendy Bindeman, Daniel Valent, Adam X Miranda, Jacob Beckstead, Barbara Fingleton
Type II Interleukin-4 Receptor Activation in Basal Breast Cancer Cells Promotes Tumor Progression via Metabolic and Epigenetic Modulation. International journal of molecular sciences 25 (9) (2024)
Demond Williams, Ebony Hargrove-Wiley, Wendy Bindeman, Daniel Valent, Adam X Miranda, Jacob Beckstead, Barbara Fingleton
Type II Interleukin-4 Receptor Activation in Basal Breast Cancer Cells Promotes Tumor Progression via Metabolic and Epigenetic Modulation. International journal of molecular sciences 25 (9) (2024)
John Tanner Wilson, Blaise Kimmel, Karan Arora, Neil C Chada, Vijaya Bharti, Alexander Kwiatkowski, Jonah Finklestein, Ann Hanna, Emily N Arner, Taylor Sheehy, Lucinda Pastora, Jinming Yang, Hayden M Pagendarm, Payton Stone, Brandie C Taylor, Lauren Hubert, Kathern Gibson-Corley, Jody C May, John A McLean, Jeffrey C Rathmell, Ann Richmond, Wendy Rathmell, Justin M Balko, Barbara Fingleton, Ebony Hargrove-Wiley
Programable Albumin-Hitchhiking Nanobodies Enhance the Delivery of STING Agonists to Potentiate Cancer Immunotherapy. Research square (2024)
John Tanner Wilson, Blaise Kimmel, Karan Arora, Neil C Chada, Vijaya Bharti, Alexander Kwiatkowski, Jonah Finklestein, Ann Hanna, Emily N Arner, Taylor Sheehy, Lucinda Pastora, Jinming Yang, Hayden M Pagendarm, Payton Stone, Brandie C Taylor, Lauren Hubert, Kathern Gibson-Corley, Jody C May, John A McLean, Jeffrey C Rathmell, Ann Richmond, Wendy Rathmell, Justin M Balko, Barbara Fingleton, Ebony Hargrove-Wiley
Programable Albumin-Hitchhiking Nanobodies Enhance the Delivery of STING Agonists to Potentiate Cancer Immunotherapy. Research square (2024)
Demond Williams, Ebony Hargrove-Wiley, Wendy Bindeman, Daniel Valent, Adam X Miranda, Jacob Beckstead, Barbara Fingleton
Type II Interleukin-4 Receptor Activation in Basal Breast Cancer Cells Promotes Tumor Progression via Metabolic and Epigenetic Modulation. International journal of molecular sciences 25 (9) (2024)
Ebony Hargrove-Wiley, Barbara Fingleton
Sex hormones in breast cancer immunity. Cancer research (2022)